QuidelOrtho Partners with Allo Hope Foundation to Enhance Prenatal Care for Maternal Alloimmunization

QuidelOrtho, a leader in diagnostic innovation (QDEL), announces a partnership with the Allo Hope Foundation to enhance prenatal care for families facing maternal alloimmunization. This collaboration aims to address maternal red blood cell alloimmunization, a condition that poses significant risks to fetal health and can lead to life-threatening hemolytic disease of the fetus and newborn (HDFN) if left undetected. By focusing on early testing, education, and strengthening the connections among healthcare providers, patients, and laboratory services, this initiative seeks to improve access to critical information and care, especially for underserved communities.

A Commitment to Maternal Health

The partnership responds to the urgent need for better resources and support for families dealing with alloimmunization. Many of these families often encounter difficulty in navigating the medical system and feel overwhelmed by their circumstances. QuidelOrtho's Executive Vice President of Global Portfolio Management and Marketing, Bryan Hanson, underscores the company's mission to advance diagnostics for a healthier future. He expresses that this collaboration with the Allo Hope Foundation is a manifestation of that commitment, ensuring that patients receive timely testing and necessary support throughout their pregnancy journey.

Improving Patient Experiences

Bethany Weathersby, the Founder and Executive Director of the Allo Hope Foundation, echoes this sentiment by emphasizing the importance of enhancing patient experiences. Families often feel isolated in their struggles, and through this partnership, the organizations aim to alleviate that sense of isolation by providing educational resources and fostering a supportive environment. Together, QuidelOrtho and the Allo Hope Foundation aspire to pave the way for better prenatal care, benefiting maternal and fetal health outcomes, particularly for those in historically underserved populations.

Transforming Prenatal Care

In conclusion, this collaboration represents a proactive approach to tackling the challenges associated with maternal alloimmunization. By utilizing their clinical expertise and trusted diagnostic capabilities, QuidelOrtho and the Allo Hope Foundation are working to empower families, raise awareness among healthcare providers, and transform prenatal care into a more equitable and informed experience for all involved.